Latest Capital Raising News

Sultan Resources pushes forward with exploration at key Lachlan Fold Belt porphyry targets while securing US OTC Market listing and maintaining a solid cash position.

Kore Potash made steady progress on its Kola Potash Project in Q1 2026, completing key marine and topographic studies while navigating design revisions and ongoing financing talks. The company’s formal sale process continues with one bidder remaining active and cash reserves at US$8.3 million.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.

Cobre Limited has secured majority control of the Sierra Atacama Copper Project in Chile through a $60 million capital raise, marking its transition from explorer to producer. The company plans extensive drilling and operational upgrades to boost production and resource confidence.

KGL Resources has secured a US$300 million streaming agreement with Wheaton Precious Metals, unlocking early construction funding for its Jervois Copper-Silver-Gold Project. The updated Baseline Economic Model highlights robust returns with a post-tax NPV8 of A$839 million and a 30% IRR, underpinning the path to production.

ACDC Metals (ASX: ADC) has acquired an option to earn full ownership of the Mount Jackson gold-silver project in Nevada’s prolific Walker Lane district, backed by a $0.935 million placement and a planned $1.56 million rights issue to fund exploration.

Forte Energy has rapidly expanded its oil and gas exploration portfolio in Alaska’s National Petroleum Reserve, acquiring over 156,000 acres including the billion-barrel Harrier Prospect and adjacent leases to Umiat Oil Field, while securing significant cost savings through lease fee suspensions.

Blue Star Helium has completed Stage 1 of its Galactica development, tying six wells into the Pinon Canyon facility and starting spot-priced helium sales. The company raised A$10 million to fund further project expansion and working capital.

Cynata Therapeutics is on the cusp of releasing critical data from its Phase 2 aGvHD and Phase 3 osteoarthritis trials in Q2 2026, while managing a tight cash runway and preparing for a capital raising.

Freehill Mining’s aggregates business surged with a 59% jump in quarterly sales, while new copper project options promise to shift the company’s growth trajectory.

Mount Ridley Mines has reported a substantial inferred mineral resource for heavy rare earths and scandium at its Western Australian project, underpinning its multi-element development strategy.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.